Women diagnosed with HER-2 positive Stage III or Stage IV breast cancer are eligible to participate in a clinical trial investigating early detection of brain metastases from advanced breast cancer through education and screening. The trial will take place on Friday, October 26th, from 1 to 9 p.m. and Saturday, October 27th, from 8 a.m. to 5 p.m. The location is the Neurologic and Orthopedic Institute of Chicago, 4501 N. Winchester, Chicago: [click link for full article]

More: continued here

This entry was posted on Tuesday, October 9th, 2007 at 6:10 am and is filed under Breast Cancer. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.